Literature DB >> 24891104

Morphogenesis is not required for Candida albicans-Staphylococcus aureus intra-abdominal infection-mediated dissemination and lethal sepsis.

Evelyn E Nash1, Brian M Peters2, Glen E Palmer1, Paul L Fidel3, Mairi C Noverr4.   

Abstract

Intra-abdominal polymicrobial infections cause significant morbidity and mortality. An established experimental mouse model of Staphylococcus aureus-Candida albicans intra-abdominal infection results in ∼60% mortality within 48 h postinoculation, concomitant with amplified local inflammatory responses, while monomicrobial infections are avirulent. The purpose of this study was to characterize early local and systemic innate responses during coinfection and determine the role of C. albicans morphogenesis in lethality, a trait involved in virulence and physical interaction with S. aureus. Local and systemic proinflammatory cytokines were significantly elevated during coinfection at early time points (4 to 12 h) compared to those in monoinfection. In contrast, microbial burdens in the organs and peritoneal lavage fluid were similar between mono- and coinfected animals through 24 h, as was peritoneal neutrophil infiltration. After optimizing the model for 100% mortality within 48 h, using 3.5 × 10(7) C. albicans (5× increase), coinfection with C. albicans yeast-locked or hypha-locked mutants showed similar mortality, dissemination, and local and systemic inflammation to the isogenic control. However, coinfection with the yeast-locked C. albicans mutant given intravenously (i.v.) and S. aureus given intraperitoneally (i.p.) failed to induce mortality. These results suggest a unique intra-abdominal interaction between the host and C. albicans-S. aureus that results in strong inflammatory responses, dissemination, and lethal sepsis, independent of C. albicans morphogenesis.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24891104      PMCID: PMC4136217          DOI: 10.1128/IAI.01746-14

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  57 in total

Review 1.  Transcription factors in Candida albicans - environmental control of morphogenesis.

Authors:  J F Ernst
Journal:  Microbiology       Date:  2000-08       Impact factor: 2.777

2.  Candida albicans RIM101 pH response pathway is required for host-pathogen interactions.

Authors:  D Davis; J E Edwards; A P Mitchell; A S Ibrahim
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

3.  Predictive factors of mortality due to polymicrobial peritonitis with Candida isolation in peritoneal fluid in critically ill patients.

Authors:  Hervé Dupont; Catherine Paugam-Burtz; Claudette Muller-Serieys; Lisiane Fierobe; Denis Chosidow; Jean-Pierre Marmuse; Jean Mantz; Jean-Marie Desmonts
Journal:  Arch Surg       Date:  2002-12

4.  Immunopathologic alterations in murine models of sepsis of increasing severity.

Authors:  S Ebong; D Call; J Nemzek; G Bolgos; D Newcomb; D Remick
Journal:  Infect Immun       Date:  1999-12       Impact factor: 3.441

5.  Tetracycline-regulatable system to tightly control gene expression in the pathogenic fungus Candida albicans.

Authors:  H Nakayama; T Mio; S Nagahashi; M Kokado; M Arisawa; Y Aoki
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

6.  Microbiologic profile of intra-abdominal infections at Belo Horizonte, Brazil.

Authors:  S G Santos; J C Serufo; R A P Silva; B A Marra; C M F Reis; J S Hamdan; J R Nicoli; M A R Carvalho; L M Farias
Journal:  Am J Infect Control       Date:  2003-05       Impact factor: 2.918

7.  Engineered control of cell morphology in vivo reveals distinct roles for yeast and filamentous forms of Candida albicans during infection.

Authors:  Stephen P Saville; Anna L Lazzell; Carlos Monteagudo; Jose L Lopez-Ribot
Journal:  Eukaryot Cell       Date:  2003-10

8.  Staphylococcus aureus adherence to Candida albicans hyphae is mediated by the hyphal adhesin Als3p.

Authors:  Brian M Peters; Ekaterina S Ovchinnikova; Bastiaan P Krom; Lisa Marie Schlecht; Han Zhou; Lois L Hoyer; Henk J Busscher; Henny C van der Mei; Mary Ann Jabra-Rizk; Mark E Shirtliff
Journal:  Microbiology       Date:  2012-08-23       Impact factor: 2.777

Review 9.  Signaling through protein kinases and transcriptional regulators in Candida albicans.

Authors:  Navneet K Dhillon; Sadhna Sharma; G K Khuller
Journal:  Crit Rev Microbiol       Date:  2003       Impact factor: 7.624

10.  Cecal ligation and puncture versus colon ascendens stent peritonitis: two distinct animal models for polymicrobial sepsis.

Authors:  Stefan Maier; Tobias Traeger; Markus Entleutner; Alexandra Westerholt; Britta Kleist; Norbert Hüser; Bernhard Holzmann; Albrecht Stier; Klaus Pfeffer; Claus-Dieter Heidecke
Journal:  Shock       Date:  2004-06       Impact factor: 3.454

View more
  25 in total

Review 1.  Candida albicans Pathogenesis: Fitting within the Host-Microbe Damage Response Framework.

Authors:  Mary Ann Jabra-Rizk; Eric F Kong; Christina Tsui; M Hong Nguyen; Cornelius J Clancy; Paul L Fidel; Mairi Noverr
Journal:  Infect Immun       Date:  2016-09-19       Impact factor: 3.441

2.  Identification of Specific Components of the Eicosanoid Biosynthetic and Signaling Pathway Involved in Pathological Inflammation during Intra-abdominal Infection with Candida albicans and Staphylococcus aureus.

Authors:  Mélanie A C Ikeh; Paul L Fidel; Mairi C Noverr
Journal:  Infect Immun       Date:  2018-06-21       Impact factor: 3.441

3.  Morphology-Independent Virulence of Candida Species during Polymicrobial Intra-abdominal Infections with Staphylococcus aureus.

Authors:  Evelyn E Nash; Brian M Peters; Paul L Fidel; Mairi C Noverr
Journal:  Infect Immun       Date:  2015-10-19       Impact factor: 3.441

4.  Candida albicans and Pseudomonas aeruginosa Interact To Enhance Virulence of Mucosal Infection in Transparent Zebrafish.

Authors:  Audrey C Bergeron; Brittany G Seman; John H Hammond; Linda S Archambault; Deborah A Hogan; Robert T Wheeler
Journal:  Infect Immun       Date:  2017-10-18       Impact factor: 3.441

5.  Prostaglandin E2 Receptor Antagonist with Antimicrobial Activity against Methicillin-Resistant Staphylococcus aureus.

Authors:  Mélanie A C Ikeh; Paul L Fidel; Mairi C Noverr
Journal:  Antimicrob Agents Chemother       Date:  2018-02-23       Impact factor: 5.191

6.  Efficacy of Candida dubliniensis and Fungal β-Glucans in Inducing Trained Innate Immune Protection Against Inducers of Sepsis.

Authors:  Amanda J Harriett; Shannon Esher Righi; Elizabeth A Lilly; Paul Fidel; Mairi C Noverr
Journal:  Front Cell Infect Microbiol       Date:  2022-06-13       Impact factor: 6.073

7.  The Neutral Vaginal pH in Mice That Is Typical of Most Mammalian Species Should Not Deter Research Using Experimental Murine Models of Candida Vaginitis.

Authors:  Paul L Fidel
Journal:  Infect Immun       Date:  2021-01-19       Impact factor: 3.441

Review 8.  The impact of the Fungus-Host-Microbiota interplay upon Candida albicans infections: current knowledge and new perspectives.

Authors:  Christophe d'Enfert; Ann-Kristin Kaune; Leovigildo-Rey Alaban; Sayoni Chakraborty; Nathaniel Cole; Margot Delavy; Daria Kosmala; Benoît Marsaux; Ricardo Fróis-Martins; Moran Morelli; Diletta Rosati; Marisa Valentine; Zixuan Xie; Yoan Emritloll; Peter A Warn; Frédéric Bequet; Marie-Elisabeth Bougnoux; Stephanie Bornes; Mark S Gresnigt; Bernhard Hube; Ilse D Jacobsen; Mélanie Legrand; Salomé Leibundgut-Landmann; Chaysavanh Manichanh; Carol A Munro; Mihai G Netea; Karla Queiroz; Karine Roget; Vincent Thomas; Claudia Thoral; Pieter Van den Abbeele; Alan W Walker; Alistair J P Brown
Journal:  FEMS Microbiol Rev       Date:  2021-05-05       Impact factor: 16.408

Review 9.  Dressed to impress: impact of environmental adaptation on the Candida albicans cell wall.

Authors:  Rebecca A Hall
Journal:  Mol Microbiol       Date:  2015-05-09       Impact factor: 3.501

Review 10.  Oropharyngeal Candidiasis: Fungal Invasion and Epithelial Cell Responses.

Authors:  Marc Swidergall; Scott G Filler
Journal:  PLoS Pathog       Date:  2017-01-12       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.